Abstract
Single photon emission computed tomography (SPECT) with thallium-201-chloride (201TI) was used in 22 patients to assess the grade of malignancy of brain tumors.
Low- and high-grade malignant gliomas could be well differentiated by calculating the Grade Index (GI), i.e., 201TI uptake in the tumor area relative to a contralateral brain region. Low-grade gliomas (WHO-grade I–II) usually showed a GI of <1.5. Tumors classified histologically as high-grade malignant (WHO-grade III–IV) had GI values greater than 1.42 and a mean value of 1.89.
Until labelled amino-acid tracers for gamma-cameras become commercially available, thallium-201 brain-SPECT can provide an independent and complementary method to CT/MRI for the differential diagnosis of grading of brain tumors. This simple technique can help to reduce sampling errors during needle biopsies of brain tumors, particularly of high-grade lesions incorrectly graded as low-grade tumors due to inadequate biopsy material. In addition, pre- and post-therapy studies can influence the strategy of therapy itself and allow an early detection of recurrences.
Similar content being viewed by others
References
Atkins HL, TF Budinger, E Lebowitz et al: Thallium-201 for medical use. Part 3: Human distribution and physical imaging properties. J Nucl Med 18 (1977) 133–140
Bergström M, VP Collins, E Ehrin, K Ericson, L Eriksson, T Greitz, C Halldin, HV Holst, B Langström, A Lilja, H Lundqvist, K Nagren: Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using (68Ga)EDTA, (11C)glucose, and (11C)methionine. J Comput Assist Tomogr 7 (1983) 1062–1066
Biersack HJ, HH Coenen, G Stöcklin, K Reichmann, A Bockisch, P Oehr, M Kashab, O Rollmann: Imaging of Brain Tumors with L-3-[123I]-Iodo-alpha-Methyl Tyrosine and SPECT. J Nucl Med 30 (1989) 110–112
Black KL, RA Hawkins, KT Kim, DP Becker, C Lerner, D Marciano: Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 71 (1989) 342–346
Britten JS, M Blank: Thallium activation of the (Na+−K+)-activated ATPase of rabbit kidney. Biochem Biophys Acta 159 (1968) 160–166
Carlin RD, K Jan: Mechanism of thallium extraction in pump perfused canine hearts. J Nucl Med 26 (1985) 165–169
DiChiro G, RA Brooks, L Sokoloff, NJ Patronas, RL Delapaz, BH Smith, PL Kornblith: Glycolytic rate and histologic grade of human cerebral gliomas. A study with (18F)fluoro-desoxyglucose and positron emission tomography. In: Heiss WD, ME Phelps: Positron Emission Tomography of the Brain. Springer-Verlag, Berlin-Heidelberg-New York (1983) 181–191
Kaiser HJ, W Reiche, U Büll: Vergleich von cerebraler Morphologie und Funktion in MRT- und SPECT-Studien in quantifizierender ROI-overlay Technik. Nucl Med 28 (1989) V 35 (abstr.).
Kaplan WD, T Takvorian, JH Morris, CL Rumbaugh, BT Connolly, HL Atkins: Thallium-201 brain tumor imaging: A comparative study with pathologic correlation. J Nucl Med 28 (1987) 47–52
Kim KT, KL Black, D Marciano, JC Mazziotta, BH Guze, S Grafton, RA Hawkins, DP Becker: Thallium-201 SPECT. Imaging of brain tumors: Methods and results. J Nucl Med 31 (1990) 965–969
L'Abbate A, A Biagine, C Michelassi, et al: Myocardial kinetics of thallium and potassium in man. Circulation 60 (1979) 776–785
Langen KJ, N Roosen, HH Coenen, JT Kuikka, T Kuwert, H Herzog, G Stöcklin, LE Feinendegen: Brain and brain tumor uptake of L-3-(123I)iodo-alpha-methyl-tyrosine: Competition with natural L-amino acids. J Nucl Med 32 (1991) 1225–1228
Rubinstein LJ: Tumors of the central nervous system. In: H. I. Firminger (ed).: Atlas of tumor pathology), 2nd Series, Fasc. 6, Armed Forces Institute of Pathology, Bethesda, Maryland 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Burkard, R., Kaiser, K.P., Wieler, H. et al. Contribution of thallium-201-SPECT to the grading of tumorous alterations of the brain. Neurosurg. Rev. 15, 265–273 (1992). https://doi.org/10.1007/BF00257803
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00257803